Selected research
Industry Research
Valbazen Anthelmintic Industry Research Report 2026
Market perspective
The global Valbazen Anthelmintic market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Valbazen Anthelmintic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Valbazen Anthelmintic is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Valbazen Anthelmintic is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Valbazen Anthelmintic include Hubei Zhongjiachem Pharmaceutical, Jiangsu Quality Horizons Pharmtech, HUBEI KEYI PHARMACEUTICAL INDUSTRY, Huazhong Pharmaceutical, Suzhou Homesun Pharmaceutical, Supharma Chem, Salius Pharma, Lasa Supergenerics Limited and K.A. Malle Pharmaceutica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Valbazen Anthelmintic market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Valbazen Anthelmintic Market by Company
Hubei Zhongjiachem Pharmaceutical
Jiangsu Quality Horizons Pharmtech
HUBEI KEYI PHARMACEUTICAL INDUSTRY
Huazhong Pharmaceutical
Suzhou Homesun Pharmaceutical
Supharma Chem
Salius Pharma
Lasa Supergenerics Limited
K.A. Malle Pharmaceutica
Fredun Pharmaceuticals
Valbazen Anthelmintic Segment by Type
Tablet
Capsule
Valbazen Anthelmintic Segment by Application
Human Use
Veterinary Use
Valbazen Anthelmintic Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valbazen Anthelmintic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valbazen Anthelmintic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valbazen Anthelmintic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Valbazen Anthelmintic manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Valbazen Anthelmintic by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Valbazen Anthelmintic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
Applications
- Human Use
- Veterinary Use
Companies covered
- Hubei Zhongjiachem Pharmaceutical
- Jiangsu Quality Horizons Pharmtech
- HUBEI KEYI PHARMACEUTICAL INDUSTRY
- Huazhong Pharmaceutical
- Suzhou Homesun Pharmaceutical
- Supharma Chem
- Salius Pharma
- Lasa Supergenerics Limited
- K.A. Malle Pharmaceutica
- Fredun Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Valbazen Anthelmintic Market Size (2021-2032)
- 2.2.2 Global Valbazen Anthelmintic Sales (2021-2032)
- 2.2.3 Global Valbazen Anthelmintic Market Average Price (2021-2032)
- 2.3 Valbazen Anthelmintic by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Capsule
- 2.4 Valbazen Anthelmintic by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Human Use
- 2.4.3 Veterinary Use
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Valbazen Anthelmintic Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Valbazen Anthelmintic Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Valbazen Anthelmintic Revenue of Manufacturers (2021-2026)
- 3.4 Global Valbazen Anthelmintic Average Price by Manufacturers (2021-2026)
- 3.5 Global Valbazen Anthelmintic Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Valbazen Anthelmintic, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Valbazen Anthelmintic, Product Type & Application
- 3.8 Global Manufacturers of Valbazen Anthelmintic, Established Date
- 3.9 Global Valbazen Anthelmintic Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hubei Zhongjiachem Pharmaceutical
- 4.1.1 Hubei Zhongjiachem Pharmaceutical Company Information
- 4.1.2 Hubei Zhongjiachem Pharmaceutical Business Overview
- 4.1.3 Hubei Zhongjiachem Pharmaceutical Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hubei Zhongjiachem Pharmaceutical Valbazen Anthelmintic Product Portfolio
- 4.1.5 Hubei Zhongjiachem Pharmaceutical Recent Developments
- 4.2 Jiangsu Quality Horizons Pharmtech
- 4.2.1 Jiangsu Quality Horizons Pharmtech Company Information
- 4.2.2 Jiangsu Quality Horizons Pharmtech Business Overview
- 4.2.3 Jiangsu Quality Horizons Pharmtech Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Jiangsu Quality Horizons Pharmtech Valbazen Anthelmintic Product Portfolio
- 4.2.5 Jiangsu Quality Horizons Pharmtech Recent Developments
- 4.3 HUBEI KEYI PHARMACEUTICAL INDUSTRY
- 4.3.1 HUBEI KEYI PHARMACEUTICAL INDUSTRY Company Information
- 4.3.2 HUBEI KEYI PHARMACEUTICAL INDUSTRY Business Overview
- 4.3.3 HUBEI KEYI PHARMACEUTICAL INDUSTRY Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 HUBEI KEYI PHARMACEUTICAL INDUSTRY Valbazen Anthelmintic Product Portfolio
- 4.3.5 HUBEI KEYI PHARMACEUTICAL INDUSTRY Recent Developments
- 4.4 Huazhong Pharmaceutical
- 4.4.1 Huazhong Pharmaceutical Company Information
- 4.4.2 Huazhong Pharmaceutical Business Overview
- 4.4.3 Huazhong Pharmaceutical Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Huazhong Pharmaceutical Valbazen Anthelmintic Product Portfolio
- 4.4.5 Huazhong Pharmaceutical Recent Developments
- 4.5 Suzhou Homesun Pharmaceutical
- 4.5.1 Suzhou Homesun Pharmaceutical Company Information
- 4.5.2 Suzhou Homesun Pharmaceutical Business Overview
- 4.5.3 Suzhou Homesun Pharmaceutical Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Suzhou Homesun Pharmaceutical Valbazen Anthelmintic Product Portfolio
- 4.5.5 Suzhou Homesun Pharmaceutical Recent Developments
- 4.6 Supharma Chem
- 4.6.1 Supharma Chem Company Information
- 4.6.2 Supharma Chem Business Overview
- 4.6.3 Supharma Chem Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Supharma Chem Valbazen Anthelmintic Product Portfolio
- 4.6.5 Supharma Chem Recent Developments
- 4.7 Salius Pharma
- 4.7.1 Salius Pharma Company Information
- 4.7.2 Salius Pharma Business Overview
- 4.7.3 Salius Pharma Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Salius Pharma Valbazen Anthelmintic Product Portfolio
- 4.7.5 Salius Pharma Recent Developments
- 4.8 Lasa Supergenerics Limited
- 4.8.1 Lasa Supergenerics Limited Company Information
- 4.8.2 Lasa Supergenerics Limited Business Overview
- 4.8.3 Lasa Supergenerics Limited Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lasa Supergenerics Limited Valbazen Anthelmintic Product Portfolio
- 4.8.5 Lasa Supergenerics Limited Recent Developments
- 4.9 K.A. Malle Pharmaceutica
- 4.9.1 K.A. Malle Pharmaceutica Company Information
- 4.9.2 K.A. Malle Pharmaceutica Business Overview
- 4.9.3 K.A. Malle Pharmaceutica Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 K.A. Malle Pharmaceutica Valbazen Anthelmintic Product Portfolio
- 4.9.5 K.A. Malle Pharmaceutica Recent Developments
- 4.10 Fredun Pharmaceuticals
- 4.10.1 Fredun Pharmaceuticals Company Information
- 4.10.2 Fredun Pharmaceuticals Business Overview
- 4.10.3 Fredun Pharmaceuticals Valbazen Anthelmintic Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Fredun Pharmaceuticals Valbazen Anthelmintic Product Portfolio
- 4.10.5 Fredun Pharmaceuticals Recent Developments
5 Global Valbazen Anthelmintic Market Scenario by Region
- 5.1 Global Valbazen Anthelmintic Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Valbazen Anthelmintic Sales by Region: 2021-2032
- 5.2.1 Global Valbazen Anthelmintic Sales by Region: 2021-2026
- 5.2.2 Global Valbazen Anthelmintic Sales by Region: 2027-2032
- 5.3 Global Valbazen Anthelmintic Revenue by Region: 2021-2032
- 5.3.1 Global Valbazen Anthelmintic Revenue by Region: 2021-2026
- 5.3.2 Global Valbazen Anthelmintic Revenue by Region: 2027-2032
- 5.4 North America Valbazen Anthelmintic Market Facts & Figures by Country
- 5.4.1 North America Valbazen Anthelmintic Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Valbazen Anthelmintic Sales by Country (2021-2032)
- 5.4.3 North America Valbazen Anthelmintic Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Valbazen Anthelmintic Market Facts & Figures by Country
- 5.5.1 Europe Valbazen Anthelmintic Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Valbazen Anthelmintic Sales by Country (2021-2032)
- 5.5.3 Europe Valbazen Anthelmintic Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Valbazen Anthelmintic Market Facts & Figures by Country
- 5.6.1 Asia Pacific Valbazen Anthelmintic Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Valbazen Anthelmintic Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Valbazen Anthelmintic Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Valbazen Anthelmintic Market Facts & Figures by Country
- 5.7.1 South America Valbazen Anthelmintic Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Valbazen Anthelmintic Sales by Country (2021-2032)
- 5.7.3 South America Valbazen Anthelmintic Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Valbazen Anthelmintic Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Valbazen Anthelmintic Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Valbazen Anthelmintic Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Valbazen Anthelmintic Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Valbazen Anthelmintic Sales by Type (2021-2032)
- 6.1.1 Global Valbazen Anthelmintic Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Valbazen Anthelmintic Sales Market Share by Type (2021-2032)
- 6.2 Global Valbazen Anthelmintic Revenue by Type (2021-2032)
- 6.2.1 Global Valbazen Anthelmintic Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Valbazen Anthelmintic Revenue Market Share by Type (2021-2032)
- 6.3 Global Valbazen Anthelmintic Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Valbazen Anthelmintic Sales by Application (2021-2032)
- 7.1.1 Global Valbazen Anthelmintic Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Valbazen Anthelmintic Sales Market Share by Application (2021-2032)
- 7.2 Global Valbazen Anthelmintic Revenue by Application (2021-2032)
- 7.2.1 Global Valbazen Anthelmintic Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Valbazen Anthelmintic Revenue Market Share by Application (2021-2032)
- 7.3 Global Valbazen Anthelmintic Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Valbazen Anthelmintic Value Chain Analysis
- 8.1.1 Valbazen Anthelmintic Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Valbazen Anthelmintic Production Mode & Process
- 8.2 Valbazen Anthelmintic Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Valbazen Anthelmintic Distributors
- 8.2.3 Valbazen Anthelmintic Customers
9 Global Valbazen Anthelmintic Analyzing Market Dynamics
- 9.1 Valbazen Anthelmintic Industry Trends
- 9.2 Valbazen Anthelmintic Industry Drivers
- 9.3 Valbazen Anthelmintic Industry Opportunities and Challenges
- 9.4 Valbazen Anthelmintic Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst